SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-19-040377
Filing Date
2019-02-14
Accepted
2019-02-14 14:51:32
Documents
1
Group Members
MACQUARIE BANK LTDMACQUARIE FUNDS MANAGEMENT HONG KONG LTDMACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUSTMACQUARIE INVESTMENT MANAGEMENT HOLDINGS INC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G d686004dsc13ga.htm SC 13G/A 132664
  Complete submission text file 0001193125-19-040377.txt   134373
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Subject) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82196 | Film No.: 19604922
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 MARTIN PLACE SYDNEY, NSW 2000 C3 2000
Business Address 50 MARTIN PLACE SYDNEY, NSW 2000 C3 2000 212.231.1000
MACQUARIE GROUP LTD (Filed by) CIK: 0001418333 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: SC 13G/A